We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$382M
AUM Growth
-$65.8M
Cap. Flow
-$64.9M
Cap. Flow %
-17%
Top 10 Hldgs %
62.43%
Holding
2,081
New
124
Increased
587
Reduced
360
Closed
164

Sector Composition

Rank Sector Weight
1 Financials 19.6%
2 Technology 13.42%
3 Consumer Discretionary 4.48%
4 Healthcare 4.37%
5 Communication Services 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
376
GE Aerospace
GE
$384B
$64K 0.02%
994
-1,344
-57% -$86.4K
GIL icon
377
Gildan
GIL
$10.6B
$64K 0.02%
1,748
AEG icon
378
Aegon
AEG
$14.1B
$63K 0.02%
12,844
-114
-0.9% -$494
AJG icon
379
Arthur J. Gallagher & Co
AJG
$63.6B
$63K 0.02%
423
CRIS icon
380
Curis
CRIS
$7.83M
$63K 0.02%
20
+2
+11% +$6.25K
FIZZ icon
381
National Beverage
FIZZ
$3.01B
$63K 0.02%
1,200
-31
-3% -$1.44K
FLEX icon
382
Flex
FLEX
$44.8B
$63K 0.02%
4,720
GPN icon
383
Global Payments
GPN
$22.8B
$63K 0.02%
399
-60
-13% -$10.4K
SAN icon
384
Banco Santander
SAN
$210B
$63K 0.02%
17,511
-752
-4% -$2.78K
TSCO icon
385
Tractor Supply
TSCO
$18B
$63K 0.02%
1,550
+45
+3% +$1.75K
PHG icon
386
Philips
PHG
$26.1B
$62K 0.02%
1,676
+180
+12% +$6.84K
WM icon
387
Waste Management
WM
$91B
$62K 0.02%
413
+17
+4% +$2.54K
BTAI icon
388
BioXcel Therapeutics
BTAI
$27.8M
$61K 0.02%
125
+94
+303% +$41.3K
KEYS icon
389
Keysight
KEYS
$58.3B
$61K 0.02%
372
+14
+4% +$2.35K
QGEN icon
390
Qiagen
QGEN
$8.72B
$61K 0.02%
1,108
+69
+7% +$3.84K
CONE
391
DELISTED
CyrusOne Inc Common Stock
CONE
$61K 0.02%
794
-11
-1% -$827
DD icon
392
DuPont de Nemours
DD
$19.2B
$60K 0.02%
698
-8
-1% -$741
IEF icon
393
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$60K 0.02%
518
LH icon
394
Labcorp
LH
$25.9B
$60K 0.02%
248
NTES icon
395
NetEase
NTES
$84.7B
$60K 0.02%
707
+66
+10% +$6.23K
SO icon
396
Southern Company
SO
$107B
$60K 0.02%
966
EMN icon
397
Eastman Chemical
EMN
$8.42B
$59K 0.02%
582
-12
-2% -$1.32K
GS icon
398
Goldman Sachs
GS
$303B
$59K 0.02%
157
+16
+11% +$6.25K
MT icon
399
ArcelorMittal
MT
$55.3B
$59K 0.02%
1,969
+34
+2% +$1.11K
OCUL icon
400
Ocular Therapeutix
OCUL
$2.02B
$59K 0.02%
5,900
-2,300
-28% -$25.8K

Similar funds

Lindbrook Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Lindbrook Capital held 2,081 positions worth $382M, down 15% from $447M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Lindbrook Capital withdrew a net $64.9M in Q3 2021, closing 164 positions and reducing 360 holdings. Its most notable exit was Eaton Vance Senior Floating-Rate Fund, an estimated $7.65M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Lindbrook Capital opened a new position in ACRES Commercial Realty worth $566K.

  • Lindbrook Capital's largest Q3 2021 buy was ACRES Commercial Realty: 35,000 shares worth $566K.
  • Lindbrook Capital added most to RPAR Risk Parity ETF in Q3 2021, an estimated $2.94M increase.
  • Lindbrook Capital's biggest Q3 2021 reduction was Nuveen Floating Rate Income Fund, cutting an estimated $13.1M.
  • Lindbrook Capital fully exited Eaton Vance Senior Floating-Rate Fund in Q3 2021, selling an estimated $7.65M.
  • Lindbrook Capital's ten largest holdings make up 62% of its $382M portfolio in Q3 2021.
  • Lindbrook Capital opened 124 new positions and closed 164 in Q3 2021.
  • Lindbrook Capital's portfolio value fell 15% quarter-over-quarter to $382M.

Based on Lindbrook Capital's 13F filing for Q3 2021, filed 5 Nov 2021.